Navigation Links
Solta Medical Launches New Fraxel re:store(R) Dual Laser System
Date:8/26/2009

HAYWARD, Calif., Aug. 26 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM) today announced the launch of its new Fraxel re:store(R) Dual system, providing superior results for large body areas during a single treatment. Prior to the non-ablative Fraxel re:store Dual system, laser skin resurfacing procedures were largely limited to the face. The Fraxel re:store Dual takes the industry leading fractional laser technology to the next level by adding a novel 1927 nm wavelength, the first ever application of a Thulium laser in the aesthetics market, optimized for treatment of pigmentation and other superficial skin conditions.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090826/AQ66272-a)

(Photo: http://www.newscom.com/cgi-bin/prnh/20090826/AQ66272-b)

"The expanded versatility of the Fraxel re:store Dual system, with the addition of the new 1927 nm wavelength, increases the areas of the body that I can treat and provides a superior treatment for pigmentation and actinic keratoses associated with photodamage," said Roy Geronemus, MD, director of the Laser & Skin Surgery Center of New York.

Vic Narurkar, MD, founder of the Bay Area Laser Institute added, "The Fraxel re:store Dual allows me to offer patients the safety, comfort and minimal downtime of a non-ablative treatment, and achieve results superior to superficial fractional CO2 treatments."

The product launch comes on the heels of Solta's announcement last week of the new Thermage CPT(TM) system for skin tightening and body contouring. Together, these cutting edge developments further secure Solta's leadership position in the aesthetic energy device industry.

"Solta Medical is committed to developing innovative, safe, and effective anti-aging solutions that enhance and expand the practice of medical aesthetics for our physician customers," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. "With the launch of a major new product from each of our industry-leading Thermage and Fraxel brands, Solta takes another step forward in fulfilling our mission to be the leader in developing transformational aesthetic treatments, building world class brands and providing long-term value for our stakeholders."

Fraxel re:store Dual system features and benefits include:

  • Dual fiber laser technology in one system providing the most effective non-ablative skin resurfacing treatment
  • Accelerated clearance of unwanted pigmentation via ground-breaking use of a Thulium laser
  • Ease of operation and improved patient comfort with focal cooling built directly into the hand piece
  • Treatment of larger and multiple body areas in a single session due to enhanced comfort profile with 1927 nm wavelength
  • Increased procedure speed by 25% with newly improved scanner design

Solta Medical is proud to be celebrating the launch of this new product along with the Thermage CPT system through the illumiNATION tour. Beginning in September and continuing through November, the illumiNATION tour will bring the new Fraxel re:store Dual system and Thermage CPT system to physicians in over 20 cities across the U.S. and 11 cities in Europe on board a state-of-the-art, custom-outfitted Airstream(R). Come join the excitement by visiting www.illuminationtour.com for more information and to register for a tour stop.

ABOUT SOLTA MEDICAL, INC.

Solta Medical is a global leader in the medical aesthetics market providing innovative, safe, and effective anti-aging solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address aging skin under the industry's two premier brands: Thermage(R) and Fraxel(R). Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Since 2002, approximately one million Thermage and Fraxel procedures have been performed in nearly 80 countries. Thermage and Fraxel are the perfect complement for any aesthetic practice. For more information about Solta Medical, call 1-877-782-2286 or log on to http://www.Solta.com.

The Fraxel re:store 1550 nm laser is FDA cleared for the treatment of pigmented lesions, acne scars, melasma, mild to moderate periorbital rhytids, surgical scars and actinic keratosis. The Fraxel re:store 1927 nm wavelength is pending FDA 510(k) clearance.

(C) 2009 Solta Medical, Inc. All rights reserved. Thermage, Fraxel, Fraxel re:store and Solta Medical are trademarks or registered trademarks of Solta Medical, Inc. or its subsidiaries.


'/>"/>
SOURCE Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Thermage, Inc. Announces Name Change to Solta Medical, Inc.
2. Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments
3. Solta Medical, Inc. Announces Preliminary Financial Results for the Fourth Quarter of 2008
4. Solta Medical Reports Fourth Quarter and Full Year 2008 Results
5. Solta Medical, Inc. Announces State-of-the-Art Aesthetic Center
6. Solta Medical, Inc. Secures $9M Credit Facility from Silicon Valley Bank
7. Solta Medical Presents Expert Roundtable about Thermage(R) and Fraxel(R) Combination Treatments at ASLMS Annual Meeting
8. Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call
9. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
10. Solta Medical, Inc. to Present at 8th Annual Needham Life Sciences Conference
11. Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: